Xaira vs Chai Discovery

Xaira Therapeutics builds AI models for target discovery and de novo antibody design, linked to agentic AI and robotic lab automation, to develop its own pipeline of drug candidates.

Biotech

Chai Discovery

Builds foundation models for biomolecular structure prediction and fully de novo antibody design.

Start your free week.

By continuing you'll get The Briefing free (one-click unsubscribe), plus a free 7-day trial of Fobi Pro.*
*To keep Fobi Pro after the trial: $4.99/month or $49/year. No card needed. Terms · Privacy

7 days of everything:

The Briefing, free: frontier tech in under 10 minutes, every morning, read or listened to. Yours to keep after the week.

30 sectors
One dashboard each, refreshed every day.
1,200+ companies
Funding, leadership, hiring, competitors.
Jobs board
Roles at companies LinkedIn never shows.
Video
What's hyped on 1,200+ official company channels.
Investors & exits
Who funds the frontier, and who bought what.
Frontline
The day's developments in every sector, scored.